Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 1.00 |
| ▸ | LCK | P06239 | 1/20 | 1.00 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.90 |
| ▸ | NPY2R | P49146 | 4/20 | 0.52 |
| ▸ | NPY1R | P25929 | 2/20 | 0.52 |
| ▸ | NPY4R | P50391 | 2/20 | 0.52 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.52 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.47 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.47 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.47 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.46 |
| ▸ | VEGFA | P15692 | 6/20 | 0.45 |
| ▸ | FLT1 | P17948 | 1/20 | 0.45 |
| ▸ | BECN1 | Q14457 | 3/20 | 0.44 |
| ▸ | TCF4 | P15884 | 1/20 | 0.44 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bacitracin SCHEMBL29603422 | 1.00 | EGFR (1.00) | EGFRLCKHKDC1NPY2RNPY1R | |
| SCHEMBL25547820 | 0.98 | EGFR (0.97) | EGFRLCKHKDC1NPY2RNPY1R | |
| SCHEMBL19712232 | 0.95 | EGFR (0.91) | EGFRLCKHKDC1NPY2RNPY1R | |
| Bacitracin SCHEMBL30071019 | 0.95 | HKDC1 (1.00) | EGFRLCKHKDC1NPY2RNPY1R | |
| SCHEMBL4352461 | 0.93 | EGFR (0.86) | EGFRLCKHKDC1NPY2RNPY1R | |
| SCHEMBL1024602 | 0.93 | EGFR (0.86) | EGFRLCKHKDC1NPY2RNPY1R | |
| SCHEMBL2274 | 0.93 | EGFR (0.86) | EGFRLCKHKDC1NPY2RNPY1R | |
| Bacitracin SCHEMBL12652843 | 0.92 | EGFR (0.85) | EGFRLCKHKDC1NPY2RNPY1R | |
| SCHEMBL31109076 | 0.90 | EGFR (0.82) | EGFRLCKHKDC1NPY2RNPY1R | |
| SCHEMBL543112 | 0.90 | EGFR (0.82) | EGFRLCKHKDC1NPY2RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-3790536-B1 | NANOCONTAINERS FOR TRANSPORTING NONPOLAR, LIPOPHILIC SUBSTANCES SUCH AS ANTIBIOTICS | KARLSRUHER INST TECHNOLOGIE (DE) | 2026-04-22 | — | — | EP | claimed |
| EP-4373495-B1 | BUDESONIDE 21-PHOSPHATE SODIUM SALT FOR USE AS ANTI-INFLAMMATORY OR ANTI-ASTHMATIC AGENT | GENETIC S P A (IT) | 2025-11-19 | — | — | EP | claimed |
| EP-3965808-B1 | USE OF PARASITES AND EXTRACELLULAR VESICLES OBTAINED FROM PARASITES IN CANCER TREATMENT | UNIV YEDITEPE (TR) | 2025-09-03 | — | — | EP | claimed |
| EP-3876949-B1 | DERMAL SKIN PROTECTANT AND CARRIER | INSPIRED MAT STRATEGIES LLC (US) | 2025-08-20 | — | — | EP | claimed |
| EP-4302829-B1 | PEPTIDE FOR USE IN PREVENTING OR TREATING MACULAR DEGENERATION | STEALTH BIOTHERAPEUTICS INC (US) | 2025-05-21 | — | — | EP | claimed |
| EP-4364725-B1 | SYSTEMS AND METHODS RELATING TO MEDICAL APPLICATIONS OF INVERSE THERMOSENSITIVE POLYMER FOAM FORMULATIONS | CRITICAL INNOVATIONS LLC (US) | 2025-04-02 | — | — | EP | claimed |
| EP-3765137-B1 | URETHRAL DELIVERY DEVICE | ASSURE MEDICAL LTD (IE) | 2025-02-26 | — | — | EP | claimed |
| EP-4347618-B1 | CYCLIC PEPTIDE ANTIBIOTICS | GENENTECH INC (US) | 2025-01-29 | — | — | EP | claimed |
| EP-3508501-B1 | USE OF ANTI-CGRP ANTIBODIES AND ANTIBODY FRAGMENTS TO PREVENT OR INHIBIT PHOTOPHOBIA OR LIGHT AVERSION IN SUBJECTS IN NEED THEREOF, ESPECIALLY MIGRAINE SUFFERERS | H LUNDBECK AS (DK) | 2024-11-06 | — | — | EP | claimed |
| EP-3139939-B1 | COMPOSITIONS AND METHODS FOR TREATING SKIN AND MUCOUS MEMBRANE DISEASES | UNIV CALIFORNIA (US) | 2023-09-06 | — | — | EP | claimed |
| EP-3122757-B1 | CHARGED LINKERS AND THEIR USES FOR CONJUGATION | HANGZHOU DAC BIOTECH CO LTD (CN) | 2023-09-06 | — | — | EP | claimed |
| EP-3636077-B1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF | CADENA BIO INC (US) | 2022-11-16 | — | — | EP | claimed |
| EP-2640393-B1 | CBP/CATENIN ANTAGONISTS FOR ENHANCING ASYMMETRIC DIVISION OF SOMATIC STEM CELLS | UNIV SOUTHERN CALIFORNIA (US) | 2022-10-12 | — | — | EP | claimed |
| EP-3641753-B1 | BACITRACIN AND/OR DAPTOMYCIN COMBINED WITH CANNABIDIOL FOR TREATMENT OF BACTERIAL INFECTIONS | UNIV SYDDANSK (DK) | 2022-09-21 | — | — | EP | claimed |
| EP-3265083-B1 | SUBSTITUTED UREA DEPSIPEPTIDE ANALOGS AS ACTIVATORS OF THE CLPP ENDOPEPTIDASE | ST JUDE CHILDRENS RES HOSPITAL (US) | 2022-07-06 | — | — | EP | claimed |
| EP-2437684-B1 | ANTERIOR SEGMENT DRUG DELIVERY | FORSIGHT VISION5 INC (US) | 2022-06-15 | — | — | EP | claimed |
| EP-3328199-B1 | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | NOVUS INT INC (US) | 2022-03-23 | — | — | EP | claimed |
| EP-3941206-A1 | NEW USES OF A MUTATED LACTONASE, AND COMPOSITIONS | Fondation Méditerranée Infection (FR) | 2022-01-26 | — | — | EP | claimed |
| EP-3344232-B1 | MICELLES FOR MUCOADHESIVE DRUG DELIVERY | UNIV MCMASTER (CA) | 2022-01-26 | — | — | EP | claimed |